PRVAPrivia Health Group, Inc.

Symbol	PRVA
Form	8-K (Items 2.02, 9.01)
Filed	2026-11-05
Price	$23.70
Today's Change	+5.83%

What Happened

Privia Health Group, Inc. filed an 8-K with the SEC on November 5, 2026, disclosing its financial results for the third quarter of fiscal year 2026 (Items 2.02 and 9.01 — Results of Operations and Financial Statements). The company reported net income of $13,768,000 for Q3 FY2026, with both basic and diluted earnings per share coming in at $0.11. Operating income for the quarter was $22,957,000, indicating that the business generated meaningful profitability at the operating level before accounting for below-the-line items.

Why It Matters

For investors, the Q3 print confirms that Privia Health is generating positive net income and solid operating income, a meaningful signal for a healthcare technology and physician enablement company that has historically operated in a growth-investment mode. The gap between operating income ($22.96M) and net income ($13.77M) suggests notable below-operating-line costs — such as interest expense, taxes, or other items — that investors should examine in the full financial statements accompanying this filing. The market's immediate reaction, a gain of nearly 6% on the day of the filing, reflects a broadly positive reception to the reported numbers. Notably, StockWatch initiated coverage of PRVA on this same date, November 5, 2026 — the Q3 results provide fresh fundamental data that investors can weigh alongside that research.

Analysis

The Q3 FY2026 results present a constructive picture at the headline level: positive EPS of $0.11 (basic and diluted) and operating income approaching $23M signal operational discipline. The ~$9.2M step-down from operating income to net income is worth scrutinizing — understanding whether that gap is driven by interest costs, a tax provision, or one-time items will be key to assessing earnings quality. The near-6% share price move on the filing date suggests the market viewed these results as at least in line with, if not ahead of, expectations. Looking ahead, investors will want to monitor whether operating income momentum is sustainable and how physician network expansion trends are progressing, as these are core drivers of Privia's long-term value proposition in the physician enablement space.

Disclaimer

This report is a news and informational summary of a publicly filed SEC disclosure. It is not investment advice, does not constitute a recommendation to buy or sell any security, and carries no rating or price target. Investors should conduct their own due diligence and consult a qualified financial adviser before making any investment decisions.

Existing Coverage

StockWatch has full coverage on PRVA, published 2026-11-05. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-11-05. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/1759655/000175965526000083/prva-20261105.htm